Yaron R. Hadari

4.4k citations

33 papers · 3.7k indexed · 1 hit paper · h-index 26

Molecular Biology top 2%
Immunology top 2%
Oncology top 5%
Cell Biology top 2%
Cellular and Molecular Neuroscience top 5%

Co-authors: Joseph Schlessinger Irit Lax Haruhiko Kouhara Yehiel Zick Noriko Gotoh Taly R. Spivak-Kroizman Dafna Bar‐Sagi S.H. Ong
Topics: Galectins and Cancer Biology (7 papers)Fibroblast Growth Factor Research (6 papers)Signaling Pathways in Disease (6 papers)
Cited by: Immunology Molecular Biology Cell Biology
Journals: Cell Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States Israel Singapore

In The Last Decade

Yaron R. Hadari

32 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Lipid-Anchored Grb2-Binding Protein That Links FGF-Receptor Activation to the Ras/MAPK Signaling Pathway

1997 734 citations Haruhiko Kouhara, Yaron R. Hadari et al. Cell profile →

Peers

Countries citing papers authored by Yaron R. Hadari

Since Specialization

Citations

This map shows the geographic impact of Yaron R. Hadari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaron R. Hadari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaron R. Hadari more than expected).

Fields of papers citing papers by Yaron R. Hadari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaron R. Hadari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaron R. Hadari. The network helps show where Yaron R. Hadari may publish in the future.

Co-authorship network of co-authors of Yaron R. Hadari

This figure shows the co-authorship network connecting the top 25 collaborators of Yaron R. Hadari. A scholar is included among the top collaborators of Yaron R. Hadari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaron R. Hadari. Yaron R. Hadari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of Small-Molecule Inhibitors that Block the GTP-Binding Pocket of K-Ras and Other Members of the Ras Superfamily of Small GTPases 2025 ·Molecular Cancer Therapeutics ·Luca Carta,(unknown),Carolina L. Bigarella,Sufang Zhang,(unknown),M. Rudolph,Charles H. Reynolds,Matthias Quick,Theresa M. Williams,(unknown),Yaron R. Hadari	0
2	Synthesis and evaluation of heteroaryl-ketone derivatives as a novel class of VEGFR-2 inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Eugene L. Piatnitski Chekler,(unknown),Alexander S. Kiselyov,(unknown),Xiaohu Ouyang,Ki Hyun Kim,Ying Wang,Yaron R. Hadari,Jacqueline Doody	9
3	Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2 2008 ·Bioorganic & Medicinal Chemistry ·Matthew A. J. Duncton,Eugene L. Piatnitski Chekler,(unknown),(unknown),Wai C. Wong,Leon M. Smith,Joel K. Kawakami,Alexander S. Kiselyov,Daniel L. Milligan,(unknown),Yaron R. Hadari,Ying Wang,Sheetal Patel,(unknown),James R. Tonra,David Surguladze,(unknown),Paul Kussie,Peter Böhlen,Jacqueline Doody	34
4	Targeted Therapy of the Insulin-Like Growth Factor-1 Receptor in Cancer 2008 ·Combinatorial Chemistry & High Throughput Screening ·(unknown),Yaron R. Hadari	13
5	Novel tricyclic azepine derivatives: Biological evaluation of pyrimido[4,5-b]-1,4-benzoxazepines, thiazepines, and diazepines as inhibitors of the epidermal growth factor receptor tyrosine kinase 2006 ·Bioorganic & Medicinal Chemistry Letters ·Leon M. Smith,Wai C. Wong,Alexander S. Kiselyov,(unknown),(unknown),Yong‐Jiang Xu,Matthew A. J. Duncton,Ki Hyun Kim,Evgueni L. Piatnitski,Jacqueline Doody,Ying Wang,(unknown),Daniel L. Milligan,John Columbus,(unknown),(unknown),(unknown),Yaron R. Hadari	25
6	Tricyclic azepine derivatives: Pyrimido[4,5-b]-1,4-benzoxazepines as a novel class of epidermal growth factor receptor kinase inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Leon M. Smith,Evgueni L. Piatnitski,Alexander S. Kiselyov,Xiaohu Ouyang,Xiaoling Chen,(unknown),Yong‐Jiang Xu,Ying Wang,(unknown),Sheetal Patel,(unknown),Daniel L. Milligan,John Columbus,Wai C. Wong,Jacqueline Doody,Yaron R. Hadari	12
7	Pyrimido-oxazepine as a versatile template for the development of inhibitors of specific kinases 2005 ·Bioorganic & Medicinal Chemistry Letters ·Weitao Pan,Hu Liu,Yong‐Jiang Xu,Xin Chen,Ki Hwan Kim,Daniel L. Milligan,John Columbus,Yaron R. Hadari,Paul Kussie,Wai C. Wong,Marc Labelle	18
8	The Docking Protein FRS2α Is an Essential Component of Multiple Fibroblast Growth Factor Responses during Early Mouse Development 2005 ·Molecular and Cellular Biology ·Noriko Gotoh,Katia Manova,Satoshi Tanaka,Michiko Murohashi,Yaron R. Hadari,(unknown),Y. Hamada,(unknown),Masataka Ito,(unknown),Hiroshi Nakazato,Masaaki Shibuya,Irit Lax,Elizabeth Lacy,Joseph Schlessinger	73
9	Role of galectin-8 as a modulator of cell adhesion and cell growth 2002 ·Glycoconjugate Journal ·Yehiel Zick,Miriam Eisenstein,(unknown),Yaron R. Hadari,Yifat Amir Levy,Denise Ronen	165
10	Galectin-8 Functions as a Matricellular Modulator of Cell Adhesion 2001 ·Journal of Biological Chemistry ·Yifat Amir Levy,Rinat Arbel‐Goren,Yaron R. Hadari,(unknown),Denise Ronen,(unknown),Benjamin Geiger,Yehiel Zick	151
11	Galectins Are Differentially Expressed in Supratentorial Pilocytic Astrocytomas, Astrocytomas, Anaplastic Astrocytomas and Glioblastomas, and Significantly Modulate Tumor Astrocyte Migration 2001 ·Brain Pathology ·Isabelle Camby,Nathalie Belot,Sandrine Rorive,Florence Lefranc,Claude‐Alain Maurage,Harald Lahm,Herbert Kaltner,Yaron R. Hadari,Marie‐Magdeleine Ruchoux,Jacques Brotchi,(unknown),Isabelle Salmon,Hans‐Joachim Gabius,Róbert Kiss	152
12	Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis 2000 ·Journal of Cell Science ·Yaron R. Hadari,(unknown),Yifat Amir Levy,(unknown),R. Alon,Rina Zakut,Yehiel Zick	215
13	Binding of Shp2 Tyrosine Phosphatase to FRS2 Is Essential for Fibroblast Growth Factor-Induced PC12 Cell Differentiation 1998 ·Molecular and Cellular Biology ·Yaron R. Hadari,Haruhiko Kouhara,Irit Lax,Joseph Schlessinger	276
14	Galectin-8: on the Road from Structure to Function. 1997 ·Trends in Glycoscience and Glycotechnology ·Yaron R. Hadari,(unknown),Rina Zakut,Yehiel Zick	29
15	A Lipid-Anchored Grb2-Binding Protein That Links FGF-Receptor Activation to the Ras/MAPK Signaling Pathwaybreakdown → 1997 ·Cell ·Haruhiko Kouhara,Yaron R. Hadari,Taly R. Spivak-Kroizman,(unknown),Dafna Bar‐Sagi,Irit Lax,Joseph Schlessinger	734
16	p75, a Member of the Heat Shock Protein Family, Undergoes Tyrosine Phosphorylation in Response to Oxidative Stress 1997 ·Journal of Biological Chemistry ·Yaron R. Hadari,Hans Häring,Yehiel Zick	42
17	Interaction between the Insulin Receptor and Its Downstream Effectors 1996 ·Journal of Biological Chemistry ·Keren Paz,(unknown),Yaron R. Hadari,Charles T. Roberts,Derek LeRoith,Yehiel Zick	43
18	Tyrosine Phosphorylation of Insulin Receptor Substrate-1 in Vivo Depends upon the Presence of Its Pleckstrin Homology Region 1995 ·Journal of Biological Chemistry ·(unknown),Daniel Schindler,Yaron R. Hadari,Simeon I. Taylor,Domenico Accili,Yehiel Zick	92
19	Modulation of protein tyrosine phosphorylation in rat insular cortex after conditioned taste aversion training. 1995 ·Proceedings of the National Academy of Sciences ·Kobi Rosenblum,Rina Schul,Noam Meiri,Yaron R. Hadari,Yehiel Zick,Yadin Dudai	64
20	Hepatic tyrosine-phosphorylated proteins identified and localized following in vivo inhibition of protein tyrosine phosphatases: effects of H2O2 and vanadate administration into rat livers 1993 ·Molecular and Cellular Endocrinology ·Yaron R. Hadari,Benjamin Geiger,Orna Nadiv,Ilana Sabanay,Charles T. Roberts,Derek LeRoith,Yehiel Zick	37

About Yaron R. Hadari

Yaron R. Hadari is a scholar working on Immunology, Molecular Biology and Cell Biology, having authored 33 papers that have together received 3.7k indexed citations. Recurring topics across this work include Galectins and Cancer Biology (7 papers), Fibroblast Growth Factor Research (6 papers) and Signaling Pathways in Disease (6 papers). The work is most often cited by research in Immunology (1.0k citations), Molecular Biology (2.9k citations) and Cell Biology (564 citations). Yaron R. Hadari has collaborated with scholars based in United States, Israel and Singapore. Frequent co-authors include Joseph Schlessinger, Irit Lax, Haruhiko Kouhara, Yehiel Zick, Noriko Gotoh, Taly R. Spivak-Kroizman, Dafna Bar‐Sagi, S.H. Ong, Graeme R. Guy and Yifat Amir Levy. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact